Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Gasser R, Pätzold S, Holzwart E, Ablasser K, Kraigher-Krainer E, Friehs I, Lewinski D, Pieske B, Mächler H, Trantiner-Yates A, Tscheliessnig KH, Mangge H, Porta S, Gasser S
Immunological Implications in Experimental Myocardial Ischaemia: MPO (Myeloperoxidase) Expression Is Differentially Regulated by Beta-Blockers, While CD80 Expression Remains Unaffected
Journal of Clinical and Basic Cardiology 2011; 14 (1-4): 16-22

PDF    Summary    Overview   

Fig. 1: MPO Experiments Fig. 2: Interleukin Pathway This Image - Fig. 3: CD80 Experiments
Figure/Graphic 3: CD80 Experiments
It shows the results from real-time PCR measurements of all CD80 experiments (o2ko: well-oxygenated, no ischaemia, no drug; n2ko: experimental ischaemia, no drug; o2at: well-oxygenated, no ischaemia, atenolol present; n2at: experimental ischaemia, atenolol present; o2neb: well-oxygenated, nebivolol present; n2neb: experimental ischaemia, nebivolol present). It can be seen that during experimental ischaemia, there is an up-regulation of CD80 expression. There is also a regulation with and without the influence of beta-blockers during myocardial ischaemia.
 
CD80 Experiments
Previous Image Next Image  


Figure/Graphic 3: CD80 Experiments
It shows the results from real-time PCR measurements of all CD80 experiments (o2ko: well-oxygenated, no ischaemia, no drug; n2ko: experimental ischaemia, no drug; o2at: well-oxygenated, no ischaemia, atenolol present; n2at: experimental ischaemia, atenolol present; o2neb: well-oxygenated, nebivolol present; n2neb: experimental ischaemia, nebivolol present). It can be seen that during experimental ischaemia, there is an up-regulation of CD80 expression. There is also a regulation with and without the influence of beta-blockers during myocardial ischaemia.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung